Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03815682
Title RPTR-147 in Patients With Selected Solid Tumors and Lymphomas
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Repertoire Immune Medicines



lung non-small cell carcinoma

clear cell renal cell carcinoma

head and neck squamous cell carcinoma

transitional cell carcinoma


Advanced Solid Tumor

ovarian cancer


Pembrolizumab + RPTR-147


Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Recruiting Duarte California 91010 United States Details
Yale Cancer Center Recruiting New Haven Connecticut 06511 United States Details
Dana Farber Cancer Institute Recruiting Boston Massachusetts 02215 United States Details
Karmanos Cancer Institute Recruiting Detroit Michigan 48201 United States Details
Carolina BioOncology Institute Recruiting Huntersville North Carolina 28078 United States Details
Sarah Cannon Research Institute Recruiting Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center Recruiting Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from for the field